Therapeutic Advances in Neurological Disorders

SJR Rank #3,425H-index: 81SJR: 1.243Best quartile: Q1Open AccessAPC: US$2,650Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

SAGE Publications Ltd

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.450.91.351.8

Subject Categories

  • NeurologyQ1
  • Neurology (clinical)Q1
  • PharmacologyQ1

Areas: Medicine · Neuroscience · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Multiple Sclerosis Research StudiesPeripheral Neuropathies and DisordersAcute Ischemic Stroke ManagementPolyomavirus and related diseasesNeurological disorders and treatmentsParkinson's Disease Mechanisms and TreatmentsMyasthenia Gravis and ThymomaEpilepsy research and treatmentAutoimmune Neurological Disorders and TreatmentsIntracerebral and Subarachnoid Hemorrhage Research

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs070140210280

Documents per Year

2022202503570105140

Detailed Information

ISSN

1756-2864, 1756-2856

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

3.57

References per Document

52.02

Coverage

2008-2026

Scope

Therapeutic Advances in Neurological Disorders delivers the highest quality peer-reviewed original research articles, reviews, and scholarly comment on pioneering efforts and innovative studies in the medical treatment of neurological conditions. The journal has a strong clinical and pharmacological focus and is aimed at an international audience of clinicians and researchers in neurology and related disciplines, providing an online forum for rapid dissemination of recent research and perspectives in this area.

Metrics from SCImago Journal Rank 2025. View on SCImago